Welcome to our dedicated page for Enhabit SEC filings (Ticker: EHAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Enhabit, Inc. filings document formal disclosures for a public home health and hospice care provider. Recent reports include 8-K material-event disclosures, Regulation FD materials, operating and financial results, risk-factor updates, shareholder voting matters and capital-structure information.
The company’s SEC record also covers material definitive agreements, including credit facilities and related debt terms, governance matters such as officer transitions, and litigation-related disclosures involving claims connected to its home health and hospice business history. These filings frame Enhabit’s regulatory reporting around healthcare operations, financing arrangements, corporate governance and stockholder matters.
Enhabit, Inc. (EHAB) director Gregory S. Rush acquired $8 per share on 10/10/2025, purchasing 3,125 shares and increasing his direct beneficial ownership to 76,043 shares. The transaction is reported on a Form 4 filed under Section 16, indicating an insider purchase rather than a derivative or sale. This purchase reflects a direct purchase of common stock and was signed by an attorney-in-fact on behalf of the reporting person.
Insider purchase reported: A director of Enhabit, Inc. (EHAB) acquired 2,344 shares of common stock on 10/10/2025 at a price of $8 per share. After the transaction the reporting person beneficially owned 18,117 shares. The Form 4 was filed by a single reporting person and signed by an attorney-in-fact.
Director Mark W. Ohlendorf reported a non-derivative purchase of 2,344 shares of Enhabit, Inc. (EHAB) on 10/10/2025 at a reported price of $8 per share. After the transaction he beneficially owned 42,646 shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person. No derivative transactions or additional explanatory remarks were disclosed.
Insider purchase reported: A Form 4 shows director Charles M. Elson acquired 2,344 shares of Enhabit, Inc. (EHAB) on 10/10/2025 at a price of $8 per share. After the transaction he beneficially owns 77,417 shares. The filing was signed by an attorney-in-fact on 10/10/2025. The report lists the transaction as a direct acquisition by the reporting person.
Insider purchase recorded on Form 4. A director, Jeffrey Bolton, purchased 4,688 shares of Enhabit, Inc. at $8 per share on 10/10/2025, increasing his total holdings to 133,241 shares. The filing indicates the purchase was reported by an attorney-in-fact and lists the reporting person as a director. No derivative transactions or additional remarks were disclosed.
Enhabit, Inc. filed a current report describing an upcoming investor-focused appearance by its leadership team. President and Chief Executive Officer Barbara Jacobsmeyer and Chief Financial Officer Ryan Solomon will take part in a fireside chat at the Jefferies 2025 Healthcare Services Conference on September 30, 2025, at 10:55 a.m. Central Time. The session will be webcast live and available for replay through the company’s investor relations website at https://investors.ehab.com.
The company has also prepared an investor presentation for this event and attached it as Exhibit 99.1. This presentation is being furnished under Regulation FD, meaning it is provided for informational purposes and is not deemed filed for liability purposes under the securities laws unless later specifically incorporated by reference.
Enhabit, Inc. received a joint Schedule 13G/A reporting that a group of related investment entities and an individual, collectively the "Reporting Persons," hold 3,853,067 shares of Enhabit common stock, representing 7.61% of the outstanding class based on 50,637,417 shares outstanding. The holdings are held across affiliated vehicles: 8 Knots Fund (2,035,999 shares, 4.02%), 8 Knots Fund II (170,645 shares, 0.34%), and other affiliated entities that together account for the aggregate position.
The filing identifies 8 Knots Management, LLC as an SEC-registered investment adviser and names Scott Green as its managing member; 8 Knots Management and Mr. Green disclaim beneficial ownership of certain sub-advised and separately managed account positions, while acknowledging shared voting and dispositive power over the disclosed aggregate position. The filing includes a joint filing agreement among the Reporting Persons and a certification that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control.
Solomon Ryan, Enhabit’s Chief Financial Officer, reported acquiring 10,000 shares of Enhabit common stock on 08/08/2025 at $7.64 per share (transaction code 'P', acquisition flag 'A'). The report shows his direct beneficial ownership increased to 193,468 shares. No derivative securities were reported in the filing.
Enhabit, Inc. (EHAB) Form 4 filed 08/07/2025 discloses an insider purchase. EVP of Hospice Operations Jeanne L. Kalvaitis acquired 22,795 shares of common stock on 08/05/2025 at an indicated price of $6.69 under transaction code “A” (award or purchase). Following the transaction, her direct ownership doubled to 45,979 shares.
No derivative transactions were reported. The filing reflects a single-person submission with direct ownership only and contains no additional remarks or explanations.